Low CD4+ T-cell surface CCR5 density as a cause of resistance to in vivo HIV-1 infection [3]

Journal of Acquired Immune Deficiency Syndromes

Volumn 34, Issue 1, 2003, Pages 114-116

  Reynes, Jacques ^a   Baillat, Vincent ^a   Portales, Pierre ^b   Clot, Jacques ^b   Corbeau, Pierre ^b,c  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b HÔPITAL SAINT ELOI   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IN VIVO STUDY; LETTER; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; VIRUS LOAD; VIRUS RESISTANCE;

CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; IMMUNITY, NATURAL; MALE; RECEPTORS, CCR5;

EID: 0042915961     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200309010-00018     Document Type: Letter

References (12)

1. Lin Y-L, Mettling C, Portales P, et al. Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection. Proc Natl Acad Sci U S A. 2002;99:15590-15595.
2. Reynes J, Portales P, Segondy M, et al. CD4+ T cell surface CCR5 density as a determining factor of viral load in HIV-1-infected individuals. J Infect Dis. 2000;181:927-932.
3. Paxton WA, Koup RA. Mechanisms of resistance to HIV infection. Springer Semin Immunopathol. 1997;18:323-340.
4. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86:367-377.
5. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med. 1997;3:338-340.
6. Marmor M, Sheppard HW, Donnell D, et al. Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection. J Acquir Immune Defic Syndr. 2001;15:472-481.
7. Fowke KR, Dong T, Rowland-Jones SL, et al. HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced β-chemokine production. AIDS Res Hum Retroviruses. 1998;14:1521-1530.
8. Paxton WA, Liu R, Kang S, et al. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of β-chemokines. Virology, 1998; 244:66-73.
9. Blaak H, van't Wout AB, Brouwer M, et al. Infectious cellular load in Human Immunodeficiency Virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples. J Virol. 1998;72:218-224.
10. Paxton WA, Kang S, Liu R, et al. HIV-1 infectability of CD4+ lymphocytes with relation to beta-chemokines and the CCR5 coreceptor. Immunol Lett. 1999;66:71-75.
11. Reynes J, Portales P, Segondy M, et al. CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression. AIDS. 2001;15:1627-1634.
12. Gervaix A, Nicolas J, Portales P, et al. Response to treatment and disease progression linked to CD4+ T cell surface CCR5 density in HIV-1 vertical infection. J Infect Dis. 2002;185:1055-1061.